Apogee Therapeutics, Inc. (APGE) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, Apogee Therapeutics, Inc. (NASDAQ:APGE) is held by 172 institutional firms.

• The percentage of Apogee Therapeutics owned by institutions changed from 97.0% in June 2025 to 100.4% in September 2025, marking a slight up trend.
• Quarterly data indicates a 7.81% shift in institutional share volume, and the annual owner count reflects an increase of 24.64%.
• Of these 172 institutional investors, 86 increased their holdings in Apogee Therapeutics, while 58 of them reduced positions, and 28 investors maintained their exposure.
• Collectively, institutional investors increased their stake in Apogee Therapeutics to 59.86Mn shares as of September 2025, a change that is up by 4.34Mn shares quarter on quarter and up 3.69Mn shares year over year.
• With 8.49Mn shares, VR Adviser, LLC commands the largest institutional position in Apogee Therapeutics as of September 30, 2025, equating to 14.25% of the company.
• Among the most significant buyers of Apogee Therapeutics during September 2025 were CITADEL ADVISORS LLC (1.10Mn), WELLINGTON MANAGEMENT GROUP LLP (917.99K), UBS Group AG (692.31K), Paradigm Biocapital Advisors LP (563.13K), Sofinnova Investments, Inc. (489.24K).
• Leading sellers of Apogee Therapeutics stock in September 2025 included ADAGE CAPITAL PARTNERS GP, L.L.C. (1.06Mn), Woodline Partners LP (812.89K), DRIEHAUS CAPITAL MANAGEMENT LLC (152.25K), FRANKLIN RESOURCES INC (121.77K), BANK OF AMERICA CORP /DE/ (115.08K).
• The top 10 institutional holders of Apogee Therapeutics for the quarter ending September 2025 included VR Adviser, LLC (8.49Mn), FMR LLC (6.92Mn), WELLINGTON MANAGEMENT GROUP LLP (4.72Mn), RTW INVESTMENTS, LP (2.71Mn), BlackRock, Inc. (2.69Mn), VANGUARD GROUP INC (2.25Mn), DRIEHAUS CAPITAL MANAGEMENT LLC (2.16Mn), Fairmount Funds Management LLC (2.05Mn), STATE STREET CORP (1.66Mn), Paradigm Biocapital Advisors LP (1.52Mn).